We are live on ! Find out more
SAGE

Sage Therapeutics
SAGE

Delisted

SAGE was delisted on the 30th of July, 2025.

Back to rankings

230 hedge funds and large institutions have $3.26B invested in Sage Therapeutics in 2020 Q3 according to their latest regulatory filings, with 39 funds opening new positions, 72 increasing their positions, 75 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

133% more funds holding in top 10

Funds holding in top 10: 3 → 7 (+4)

121% more call options, than puts

Call options by funds: $59.6M | Put options by funds: $27M

56% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 25

45% more capital invested

Capital invested by funds: $2.25B → $3.26B (+$1.01B)

6% more funds holding

Funds holding: 216 → 230 (+14)

0.81% less ownership

Funds ownership: 104.05% → 103.25% (-0.81%)

4% less repeat investments, than reductions

Existing positions increased: 72 | Existing positions reduced: 75

Holders
230
Holders Change
+14
Holders Change %
+6.48%
% of All Funds
4.64%
Holding in Top 10
7
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+133.33%
% of All Funds
0.14%
New
39
Increased
72
Reduced
75
Closed
25
Calls
$59.6M
Puts
$27M
Net Calls
+$32.6M
Net Calls Change
+$24M

Top Buyers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$47.7M
2
MWNA
Marshall Wace North America
New York
+$21.4M
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$17.3M
4
LGM
Logos Global Management
California
+$12.7M
5
ACP
Acuta Capital Partners
California
+$11.4M

Top Sellers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
-$31.9M
2
CCM
Camber Capital Management
Massachusetts
-$21.8M
3
Capital International Investors
Capital International Investors
California
-$18.6M
4
Citadel Advisors
Citadel Advisors
Florida
-$17.2M
5
Two Sigma Investments
Two Sigma Investments
New York
-$15.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
Wolverine Trading
151
Wolverine Trading
Illinois
$331K -$29.4K -580 -9%
TCM
152
Teza Capital Management
Illinois
$321K -$520K -10,258 -66%
WMSA
153
Weiss Multi-Strategy Advisers
New York
$308K +$2.84K +56 +1%
TC
154
Tarsadia Capital
New York
$306K -$1.01M -20,000 -80%
FBC
155
Fairfield, Bush & Co
Connecticut
$306K – – –
GCP
156
GSA Capital Partners
United Kingdom
$290K +$240K +4,744 New
QT
157
Quantamental Technologies
New York
$287K -$35.5K -700 -13%
B
158
Bailard
California
$275K +$228K +4,500 New
Mirae Asset Global Investments
159
Mirae Asset Global Investments
South Korea
$271K +$225K +4,434 New
PAMU
160
Pictet Asset Management (UK)
United Kingdom
$269K +$223K +4,400 New
SAM
161
Shell Asset Management
Netherlands
$268K – – –
NICM
162
Neo Ivy Capital Management
New York
$262K +$218K +4,295 New
Barclays
163
Barclays
United Kingdom
$233K -$712K -14,050 -79%
SWA
164
Sutton Wealth Advisors
Florida
$233K – – –
JMPWA
165
JP Morgan Private Wealth Advisors
California
$228K +$189K +3,729 New
LPL Financial
166
LPL Financial
California
$224K +$185K +3,658 New
Bank of Montreal
167
Bank of Montreal
Ontario, Canada
$218K +$81K +1,598 +88%
Canada Life
168
Canada Life
Manitoba, Canada
$211K – – –
Holocene Advisors
169
Holocene Advisors
New York
$200K -$88.5K -1,746 -35%
Pacer Advisors
170
Pacer Advisors
Pennsylvania
$177K +$147K +2,903 New
US Bancorp
171
US Bancorp
Minnesota
$173K +$97.8K +1,930 +213%
Macquarie Group
172
Macquarie Group
Australia
$137K – – –
TRCT
173
Tower Research Capital (TRC)
New York
$114K -$110K -2,179 -54%
BAM
174
Belpointe Asset Management
Nevada
$108K +$89.2K +1,760 New
Lazard Asset Management
175
Lazard Asset Management
New York
$101K -$329K -6,493 -80%
5 6
7
8 9

SAGE Hedge Fund Activity: Q3 2020 in Review

230 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Sage Therapeutics (SAGE) for Q3 2020, worth a combined $3.26B — up 45% from $2.25B a quarter earlier.

Buyers outnumbered sellers: 39 funds opened new SAGE positions and 25 closed out — a net gain of 14 holders — while 72 added to existing stakes and 75 trimmed.

The largest buyer was Adage Capital Partners, opening a new position worth an estimated $47.7M. The largest seller was State Street, cutting an estimated $31.9M.

  • 230 institutional investors held Sage Therapeutics (SAGE) as of Q3 2020, up from 216 in Q2 2020.
  • Funds reported $3.26B of Sage Therapeutics stock for Q3 2020, up 45% quarter-over-quarter.
  • 39 funds opened new Sage Therapeutics positions in Q3 2020 and 25 closed out, a net change of +14 holders.
  • The largest Sage Therapeutics buyer in Q3 2020 was Adage Capital Partners, an estimated $47.7M added.
  • The largest Sage Therapeutics seller in Q3 2020 was State Street, an estimated $31.9M sold.

Based on aggregated 13F filings for Q3 2020.